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Abstract
Dengue is the most important vector-borne viral disease worldwide and a major cause of childhood fever burden in Sri
Lanka, which has experienced a number of large epidemics in the past decade. Despite this, data on the burden and
transmission of dengue virus in the Indian Subcontinent are lacking. As part of a longitudinal fever surveillance study, we
conducted a dengue seroprevalence survey among children aged ,12 years in Colombo, Sri Lanka. We used a catalytic
model to estimate the risk of primary infection among seronegative children. Over 50% of children had IgG antibodies to
dengue virus and seroprevalence increased with age. The risk of primary infection was 14.1% per year (95% CI: 12.7%–
15.6%), indicating that among initially seronegative children, approximately 1 in 7 experience their first infection within 12
months. There was weak evidence to suggest that the force of primary infection could be lower for children aged 6 years
and above. We estimate that there are approximately 30 primary dengue infections among children ,12 years in the
community for every case notified to national surveillance, although this ratio is closer to 100:1 among infants. Dengue
represents a considerable infection burden among children in urban Sri Lanka, with levels of transmission comparable to
those in the more established epidemics of Southeast Asia.
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Introduction
Dengue is considered to be the most important mosquito-borne
viral disease affecting humans today [1]. Between 50–100 million
cases occur worldwide each year, resulting in an estimated
500,000 hospitalizations and 20,000 deaths; approximately two-
thirds of the world’s population lives in areas colonized by Aedes
mosquitos, the principal vector for dengue viruses [2].
Dengue viruses thrive in urban areas that support large Aedes
populations and close contact between infectious vectors and
susceptible human hosts [1,3]. Dengue was first serologically
confirmed in Sri Lanka in 1962, with the first island-wide outbreak
being reported in 1965 [4]. Although Sri Lanka has had a history
of over 40 years of dengue, since the early 2000s, progressively
large epidemics have occurred at regular intervals. Dengue
transmission in Sri Lanka is endemic, but unusually large
epidemics were experienced in 2004 and 2009 with the peak
transmission occurring in June, following the southwesterly
monsoon. Dengue is now considered to be hyperendemic in Sri
Lanka, involving co-circulation of multiple serotypes [5,6]. In
2012, 44,456 dengue cases were notified, corresponding to a rate
of 220 per 100,000 population; approximately a quarter of notified
cases occur in children under 15 years. Despite this, little is known
about the epidemiology of dengue and the transmission of dengue
viruses among children in Sri Lanka, in whom the risk of severe
forms of the disease, including dengue haemorrhagic fever (DHF)
and dengue shock syndrome (DSS), is considerably higher. In this
paper, we estimate the risk of dengue primary infection among
dengue-naive individuals using data from a seroprevalence survey
in the paediatric population of Colombo, Sri Lanka.
Methods
Ethics statement
Ethical approval for the study was obtained from the Ethical
Review Committee of the Faculty of Medicine, University of
Colombo. Permission to conduct the study was obtained from the
Special Commissioner of the Colombo Municipality and the Chief
Medical Officer of Health, Municipal Council Colombo. Ethical
approval was also obtained from the following institutions: The
Human Subjects Protection Committee of the Pediatric Dengue
Vaccine Initiative, International Vaccine Institute, Korea; The
Research Committees of the Lady Ridgeway Children’s Hospital
and Medical Research Institute, Sri Lanka; The Advisory
Committee on Communicable Diseases, Ministry of Health, Sri
Lanka; The Ethical Review Committee of the University of North
Carolina, Chapel Hill, USA; The Ethical Review Committee of
the London School of Hygiene & Tropical Medicine, UK. History
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of vaccination against Japanese Encephalitis (JE) virus was
ascertained by parental consent and verified from vaccination
records where available. Signed, informed consent to take part in
the study was obtained from the child’s parent or guardian.
Seroprevalence survey
A census of Municipal Council Ward 33 (MCW33), Colombo,
was carried out between September and October 2008 to enumerate
all households and children ,12 years in the area. MCW33 covers
an area of 37.3 km2 and comprises a relatively homogeneous
population of low-income families. The population of children ,12
years at the last census in 2001 was 4737. Prior to the census, a digital
map of the area was constructed and the area divided into census
blocks. In each block, a designated field worker visited every
residence and obtained information on all children ,12 years living
in the household and socioeconomic characteristics of the household.
Following the census, 802 children from 504 randomly selected
households were recruited into the study. Selection of households
within blocks was proportional to population size. Recruitment took
place between November 2008 and January 2009. Children were
excluded if they were at increased risk of harm following a blood
draw, had hemophilia, leukemia or thrombocytopenic purpura. At
enrolment, a baseline dengue seroprevalence survey was conducted.
A fingerprick blood sample was taken from every child on filter paper
strips for antibody testing (Dried Blood Spot Saver Cards
manufactured by ID Biological Systems, Greenville, South Carolina,
USA: Ref IDBS1003). Each sample was labeled, air dried and
transported in a special container to the study laboratory at the end
of the day. History of vaccination against Japanese Encephalitis (JE)
virus was ascertained from parents or legal guardians and verified
from vaccination records where available. The data used in this
analysis come from this baseline seroprevalence survey.
Laboratory analysis
The dried blood spot samples were stored with desiccants at
220uC until testing. Dengue virus seropositivity was determined
by dengue IgG ELISA as previously described [7] and OD values
$0.3 were considered flavivirus antibody positive.
Data analysis
This analysis includes data from 797 children for whom age on the
date of the baseline sample could be confirmed. We used a catalytic
model to estimate the dengue force of infection among dengue naive
children from age-specific seroprevalence data [8]. In the context of
dengue, this approach has a specific interpretation. Dengue can
result from infection with any one of four viral serotypes. Infection
with one serotype provides long-term protection to that serotype, but
not to others. Unlike for other common childhood immunizing
infections, therefore dengue seropositive individuals could still be
susceptible to secondary, heterotypic infections. However, ELISA
tests cannot distinguish between dengue serotypes and current
dengue diagnostics cannot reliably determine how many infections
an individual has experienced. For the purposes of this analysis, we
use the term ‘‘force of infection’’ specifically to mean the annual risk
of infection with any serotype among dengue-naive (seronegative)
individuals. This is equivalent to the rate of seroconversion, and we
use the two terms interchangeably.
The catalytic model predicts that the proportion of seronegative
individuals declines with increasing age at a constant rate, l,
according to the relationship:
pa~e
{la
where pa is the proportion seronegative by age a years. Assuming
that the risk of infection is constant over time, the force of infection
parameter, l, defines the rate at which seroconversion (first
infection) increases with age. The above model can be expressed
within a generalized linear modelling framework, such that:
-ln pað Þ~la
where l can be estimated by maximum likelihood regression
methods. The model can be generalized to allow the force of
infection to vary with age. We fitted two different models to our
seroprevalence data, Model 1 assuming a constant force of
infection, and Model 2 the force of infection to vary with age:
{ln pað Þ~la ðModel 1Þ
{ln pað Þ~l1a1zl2a2 ðModel 2Þ
In Model 2, a1 and a2 are linear terms of age for two different age
groups, 0.5 to ,6 years and 6 to ,12 years respectively; l1 and l2
are estimates of the force of infection in each age group. a and a1
are constrained to be $0.5 years, as seropositivity below this age is
likely to represent presence of maternal antibody. We estimated
the force of infection parameters, with corresponding 95%
confidence intervals (95% CIs) using logistic models with a log
link. Although our survey sample included children from the same
household, accounting for household level clustering made a
negligible difference to our estimates. We therefore ignored the
clustering, and used the likelihood ratio (LR) test to determine the
level of statistical support for the model with age-varying force of
infection over the model assuming a constant force of infection.
Sensitivity analysis
We investigated the sensitivity of Model 2 to different age
groupings by varying the age breakpoint by one year above and
below the cut-off of 6 years. We used AIC to compare model fit,
favouring the model with the lowest AIC value.
Author Summary
Dengue is an increasing problem in the Asian subconti-
nent, but little research exists on dengue burden and
transmission in this region. Dengue ranges from mild fever
to pronounced circulatory shock and potentially death.
However, clinical disease gives an incomplete picture of
how much dengue is circulating, because many infections
are asymptomatic. Presence of antibodies to dengue virus
provides evidence of past infection. By studying how
antibody prevalence changes with age, the force of
infection can be estimated, a key measure of population
transmission that quantifies the risk of a first infection
among dengue-naive (seronegative) individuals. We esti-
mated the force of dengue primary infection by applying a
catalytic model to data from a serological study of children
in Colombo, Sri Lanka. Over 70% of children experienced at
least one infection by the age of 12 years, and the median
age at infection was 4.7 years. Among dengue-naive
children 14% can be expected to experience a dengue
infection within 12 months. The high force of infection at
young ages indicates a very high level of dengue virus
transmission in this urban setting that is comparable with
levels seen in other regions with well-established epidem-
ics, including Southeast Asia and Latin America.
Dengue Infection in Sri Lanka
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We also investigated the effect of JE vaccination history, to
determine whether there was evidence that JE seropositivity
interfered with the flavivirus ELISA. We hypothesized two
possible scenarios: 1) that a substantial fraction of flavivirus
positive ELISA results were due to infection with JE virus rather
than dengue virus; 2) that the results of the flavivirus ELISA were
influenced by the presence of vaccine-derived antibodies to JE
virus. In either scenario, we expected that the force of infection
estimates would be different between JE vaccinees and non-
vaccinees, which would be manifested in a statistical interaction
between JE vaccination history and age. Conversely, if the
flavivirus ELISA results are not influenced by JE seropositivity,
no such interaction should be present, and the force of infection
estimates should be similar in both JE vaccinees and non-
vaccinees. We evaluated the association between JE vaccination
and flavivirus seropositivity using the x2 test, and compared the
median age of JE-vaccinated and non-vaccinated children using
the Kruskall-Wallis test. We then fit logistic models as above, but
additionally including terms for the interaction between age and
JE vaccination status, to determine whether force of infection
estimates differed between JE vaccinees and non-vaccinees. We
compared the age-specific force of infection parameters for
vaccinees and non-vaccinees, and used the LR test to assess
evidence for the interaction term. We also fitted models including
JE vaccination as a covariate, to assess potential confounding of
the force of infection parameter by JE vaccination status. We
compared the force of infection parameters from models with and
without the JE vaccination variable to assess evidence of
confounding, and used the Wald test to assess evidence of an
effect of JE vaccination history on serological status.
Ratio of dengue infections to notified cases
The number of dengue infections far exceeds the number of
clinical and notified cases, because many infections are asymp-
tomatic and only a fraction of clinical dengue cases seek medical
care and are notified to the authorities. We estimated, for the
Colombo Municipal Council (CMC), the ratio of infections to
notified cases for the year 2009. We obtained the expected size of
the paediatric population, by single year of age, by applying an
annual population growth factor of 0.7% to population estimates
from the 2001 census (Department of the Census, Sri Lanka,
personal communication). To estimate the number of dengue
primary infections, we applied our age-specific estimates of force of
infection to the age distribution of the paediatric population in
CMC, discounting from each single-year age group the number of
seroconversions expected to have occurred in the previous year.
We divided the age-specific number of primary infections by the
number of DF/DHF cases notified to the Ministry of Health in
2009 to obtain the ratio of infections to notified cases. Because of
difficulties in differentiating between infection and maternal
antibody, we excluded infants ,6 months old from the analysis.
Results
Table 1 shows the number and percentage of children positive
for flavivirus antibodies. Overall 51.4% (407) of children were
seropositive. There was an increasing trend with age, from 7.4%
(2) among infants between 6 and 12 months to 71.7% (38) by the
age of 11 years. Among 25 infants ,6 months of age, 33.3% were
seropositive, indicating that there is substantial acquisition of
maternal antibodies among infants in this population. The median
age at seroconversion was 4.7 years.
Logistic model
Force of infection estimates from Models 1 and 2 are shown in
Table 2. Assuming a constant force of infection (Model 1), dengue-
naı̈ve children seroconvert at a rate of 14.1% per year (95% CI:
12.7%–15.6%). Under Model 2, the annual rate of seroconversion
was 15.4% (95% CI: 13.2%–17.7%) among children aged 6
months to ,6 years, and 8.7% (95% CI: 2%–15.4%) among
children aged 6 to ,12 years. The LR test showed only weak
evidence to favour Model 2 (p = 0.111). Similarly, a z-test
comparing the l1 and l2 parameters from Model 2 showed only
weak evidence that these were significantly different (p = 0.109).
The model predictions are plotted together with the observed age-
specific seroprevalences (and 95% CIs) in Figure 1. Despite weak
evidence in to support Model 2, the predictions from this model
appear to provide a slightly better fit to the observed seroprev-
alence values, particularly for children above 6 years.
Table 1. Number and percentage of children positive for
flavivirus antibodies, Colombo, Sri Lanka, 2008–9.
95% CI
Age (years) Seropositive Total % positive Lower Upper
,0.5 8 25 33.3% 15.6% 55.3%
0.5 2 28 7.4% 0.9% 24.3%
1 11 59 19.0% 9.9% 31.4%
2 17 59 28.8% 17.8% 42.1%
3 28 73 38.9% 27.6% 51.1%
4 22 57 38.6% 26.0% 52.4%
5 36 71 50.7% 38.6% 62.8%
6 38 67 56.7% 44.0% 68.8%
7 49 73 67.1% 55.1% 77.7%
8 60 91 65.9% 55.3% 75.5%
9 46 66 69.7% 57.1% 80.4%
10 52 74 70.3% 58.5% 80.3%
11 38 54 71.7% 57.7% 83.2%
doi:10.1371/journal.pntd.0002259.t001
Figure 1. Observed prevalence by age (with 95% CIs) and
model-predicted values. Blue line: Model 1 (constant force of
infection); Red line: Model 2 (different forces of infection above and
below 6 years).
doi:10.1371/journal.pntd.0002259.g001
Dengue Infection in Sri Lanka
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Sensitivity analysis
For Model 2, varying the age breakpoint to 5 and 7 years
changed the l1 estimate between 15.5% and 15.1%, but the value
of l2 was quite sensitive to changes in the age breakpoint, ranging
from 10.4% to 6.7%.
JE vaccination
Overall, 514 (64.5%) children had received JE vaccination. JE
vaccination status was missing for 23 (2.9%) children. Among
children aged 1 year, 35% of children had received JE vaccine,
while above the age of 3 years, between 73% and 81% of children
were vaccinated. Children vaccinated against JE were more likely
to be seropositive (56.8% vs 41.9%, OR = 1.83, 95% CI: 1.34–
2.50). However, this association was markedly reduced after
adjusting for differences in the age distribution of vaccinees and
non-vaccinees (age-adjusted OR = 1.22, 95% CI: 0.87–1.73).
There was no evidence that JE vaccination history had any
influence on dengue force of infection estimates (Figure 2). The
force of infection parameters for JE vaccinees and non-vaccinees
were similar for Model 1 assuming a constant force of infection.
For Model 2, the force of infection was somewhat lower among JE
vaccinees aged 6 to ,12 years, but there was little statistical
support for the interaction parameter (LR test p-value = 0.861).
Adjusting for JE vaccination status had little influence on the force
of infection estimates.
Ratio of infections to notified cases
We estimated that approximately 27,000 primary dengue
infections occurred in children aged six months to 11 years in
CMC in 2009. The estimates were similar for Model 1 (27,913)
and Model 2 (26,185), although the latter estimated a higher
number of infections in children ,6 years and fewer infections
among those aged 6 years and above compared with Model 1. In
the same year, 878 cases of DF/DHF were notified to the Ministry
of Health. Thus, for every case of DF/DHF notified, an additional
30 primary dengue infections occur in the community. There was
evidence that this ratio was age dependent, being much higher in
the first two years of life than at older ages (Figure 3). Based on
Model 1, we estimated an overall primary infection rate in
children ,12 years of 68 per 1000 children per year (95% CI: 65–
70), as compared with a rate of 2.1 notified cases per 100,000
children per year. Primary infection rates based on Model 2 were
similar (64 per 1000 children per year)
Discussion
To our knowledge, this is the first study from the Asian
subcontinent to present data on dengue seroconversion rates
among children. Our study population also includes pre-school
age children, which have not always been included in similar
studies in other settings. Our findings indicate that transmission of
dengue among the paediatric population of Colombo is high;
among dengue naı̈ve children, approximately 14% experience
their first dengue infection (seroconvert) within 12 months. There
was some suggestion in our data that this risk could be age-
dependent; from our Model 2 estimates, the rate of seroconversion
among children aged 6 to ,12 years was lower at 8%. Although
there was only weak statistical support for this age dependence,
our sample size was modest and our study may have lacked power
to detect age-dependent effects. Nevertheless, Model 2 predictions
did provide a slightly better visual fit to the data at older ages,
while the marked change in the force of infection parameters with
age suggest that a lower rate of seroconversion among those aged 6
years and above could be plausible. If true, this would indicate a
lower infection pressure at older ages. A possible reason for this
could be changes in behaviour with age; school-age children spend
more time outside the home, which may reduce exposure to bites
by the primarily domestic, indoor-biting Aedes aegypti mosquito, the
main dengue vector in Sri Lanka. Studies in other countries have
indicated that dengue transmission clusters primarily around the
home [9,10], although house-to-house movements appear to be
important for maintaining transmission in an urban environment
[11]. Despite this, the two models provide similar estimates of the
expected number of primary infections by age 12. A reduction in
the rate of seroconversion above 6 years of age has a small impact,
because most children experience their first infection at a younger
age; the median age at first infection in this population was less
than 5 years.
Our findings are comparable to those of other studies in
Southeast Asia and Brazil. The median age at first infection is less
than 5 years in Colombo. A recent seroprevalence survey in
Recife, Brazil, indicated that over 50% of children in areas of
intermediate and high deprivation are seropositive before the age
of 10 years [12], while a recent study in Vietnam found that
seroprevalence was approximately 50% by the time children enter
primary school [13]. Seroprevalences of 23%, 9% and 17% at 9,
12 and 18 months of age were reported in a recent study in
Bangkok, similar, though somewhat lower, than those found in our
study [14]. Our force of infection estimates are also similar to those
in other studies. Using similar methods with seroprevalence data,
Braga et al. estimated the force of infection across all ages in a
deprived area of Recife at 17%, with lower forces of infection in
wealthier areas of the city [12]. Other studies have used
longitudinal approaches to measure seroconversion rates empir-
ically. Using repeat serological surveys two years apart, Teixeira et
al. recently reported a seroconversion rate equivalent to 17% per
year among children aged ,3 years in Salvador, Brazil. In
Vietnam, cohort studies have reported one-year seroconversion
Table 2. Force of infection estimates for Models 1 (constant force of infection) and 2 (age-varying force of infection).
95% CI LR test
Model Parameter Description Estimate Lower Upper p-value AIC1 p-value2
Model 1 l Constant force of infection 0.141 0.127 0.156 ,0.001 1.233
Model 2 l1 Force of infection between 6 months
and ,6 years
0.154 0.132 0.177 ,0.001 1.232 0.111
l2 Force of infection between 6 and ,12 years 0.087 0.020 0.154 0.011
1AIC: Akaike’s Information Criterion;
2p-value from likelihood ratio test.
doi:10.1371/journal.pntd.0002259.t002
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rates of 11% among children aged 2 to 15 years in the Mekong
Delta [15], and 17% among primary school children aged 7 years
and above in the southeastern coastal area. [13]. Among
elementary schoolchildren in Kamphaeng Phet, Thailand, dengue
infection incidence varied between 7.9% and 2.1% per year
between 1998 and 2000, although this latter study did not report
results separately for dengue-naı̈ve and previously infected
children [16].
We estimate that there are approximately 30 primary dengue
infections in the community for every DF/DHF case notified to
national surveillance. This ratio was much higher among children
less than two years of age than in older age groups. This is partly
because older children are more likely to experience secondary
infections, which we were unable to estimate from our data. Our
figures thus underestimate of the true ratio of infections to
notifications at older ages However, the ratio was four times higher
among children ,2 years compared with those aged 6 years and
above, which suggests a real differences even accounting for
additional secondary infections at older ages. Such a difference is
likely to result from a higher ratio of asymptomatic to clinical
dengue among very young children; older age has been found to
carry a greater risk of symptomatic dengue given infection, both in
Latin America [17] and Southeast Asia [18]. The high burden of
subclinical dengue, particularly at younger ages, represents a large
pool of undetected infection. The importance of this pool of
asymptomatic infection for transmission of dengue viruses remains
to be determined.
Our study is subject to a number of limitations. Firstly, our
serology results were from a flavivirus rather than dengue-specific
ELISA. This could result in inaccurate force of infection estimates
if antibodies to flaviviruses other than dengue were being detected.
The most important of these is JE virus, which is endemic in Sri
Lanka. If substantial levels of seropositivity against JE virus were
being detected, we would expect that the force of infection
estimates would differ between those with and without evidence of
JE antibodies. We investigated this using JE vaccination history as
a proxy for JE virus seropositivity and we found no evidence for
such an effect, indicating that primarily dengue infections were
being detected by our ELISA. In addition, high levels of JE virus
circulation in our study are unlikely, as this virus is largely confined
to rural areas of the country. An analogous finding was reported
from a study in the Amazonian basin, in which dengue virus
seropositivity was not affected by prior yellow fever vaccination
[19]. In addition, we assumed that maternal antibody wanes by 6
months of age. The large drop in seroprevalence between 0 and 6
months suggests that this is a reasonable assumption. However,
studies have shown persistence of maternal antibody in a minority
of children beyond 12 months [14,20,21]. It is therefore possible
that our models overestimate seroprevalence at these ages, which
would have resulted in an underestimate of the rates of
seroconversion.
Unlike in other childhood immunizing infections, a first
infection with dengue does not provide long-term protection from
re-infection, as individuals are still susceptible to infection with
other dengue serotypes. Diagnosis of past dengue infection is
complicated by the fact that, beyond the first infection, no method
can reliably determine the serotypes to which an individual has
been exposed. We were thus unable to estimate serotype-specific
Figure 2. Force of dengue infection estimates and 95% CIs by JE vaccination status. Model 1: constant force of infection; Model 2: different
forces of infection above and below 6 years. Figure 2 footnote: * Estimates from a model adjusting for JE vaccination status.
doi:10.1371/journal.pntd.0002259.g002
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forces of infection; our estimates are better interpreted as the
average force of first infection with any serotype. For this reason,
we are also unable to comment on the risk of infection among
seroconverters, which would require longitudinal approaches and/
or diagnostics that are better able to differentiate between primary
and secondary infections. Ferguson et al. previously estimated
strain-specific forces of infection in Thai children under 10 years
by applying a mathematical model to data from cross-sectional
serological samples tested by plaque reduction neutralization tests,
which can differentiate between strain-specific monotypic infec-
tions and multitypic infections [22]. Their serotype-specific force
of infection estimates ranged from 0.01 to 0.1, and were highest for
the DEN-2 serotype. Strain-specific forces of infection will depend
on the relative frequency of circulation of each serotype, as well as
any interactions between strains.
Our model assumes that the force of infection is constant over
time. This may not be true in highly epidemic years, or if changes
to the force of infection occur because of shifts in the predominant
circulating strains. Such effects would likely result in cohort effects
in the data, such as spikes in the prevalence of seropositivity in
children of a specific age. Sri Lanka experienced a number of
highly epidemic years prior to the study, most notably in 2004, but
there is little evidence in our data of such cohort effects, suggesting
that any temporal changes in the force of infection are minimal.
In estimating the number of dengue infections, we have
extrapolated results from MC Ward 33 to the entire CMC region.
It is possible that the force of infection in other areas of Colombo
differs from that in our study area, because of differences in
demographic or socioeconomic characteristics, or population and/
or vector densities, although we have little reason to believe that
our results would not be applicable to other areas of CMC.
Our study has important implications, both for understanding
dengue transmission and developing control strategies. Our findings
confirm that there is a high infection pressure at young ages, as more
than half of children experience their first infection before the age of
5 years. This age group is also at highest risk of mortality. The high
level of transmission at very young ages, suggests that control
strategies and future vaccination schedules that focus these age
groups are likely to provide the most benefit. It also suggests that
transmission in Colombo primarily occurs in and around the home,
as more than half of children seroconvert before they reach school
age. Finally, a number of studies have indicated that transitions in
dengue epidemiology, characterized by shifts in the average age of
cases, are related to the force of infection [23] [24]. Brazil, where
historically adults contribute the majority of cases, is currently seeing
a trend towards infection and more severe disease at younger ages
[24,25]. Conversely, secular decreases in birth rates in Thailand are
thought to be linked with declines in the force of infection and a
resulting increase in the average age of dengue infection [23]. In Sri
Lanka, high forces of infection, the predominance of cases in
childhood, and a recent trend towards a greater contribution to the
caseload among adults all indicate that the epidemic is at an
equivalent stage to the well-established epidemics in Southeast Asia.
Supporting Information
Checklist S1 STROBE checklist.
(DOC)
Figure 3. Ratio of dengue infections to notified cases by age in Colombo Municipal Council, 2009. Blue line: Model 1 (constant force of
infection); Red line: Model 2 (different forces of infection above and below 6 years).
doi:10.1371/journal.pntd.0002259.g003
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